SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Orange S.A. (ORANY) trades at a trailing P/E of 90.7, forward P/E of 17.0. Trailing earnings yield is 1.10%, forward earnings yield 5.88%. PEG 0.04 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 90.7).
- Forward P/E 17.0 (down from trailing 90.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.04 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1.10% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 5.88% as earnings recover.
Overall SharesGrow Score: 47/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ORANY
Valuation Multiples
P/E (TTM)90.7
Forward P/E17.0
PEG Ratio0.04
Forward PEG0.04
P/B Ratio0.00
P/S Ratio2.91
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.23
Forward EPS (Est.)$1.23
Book Value / Share$0.00
Revenue / Share$7.17
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.10%
Forward Earnings Yield5.88%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.21 |
$45.26B |
$551.99M |
1.2% |
| 2017 |
$0.67 |
$46.09B |
$1.78B |
3.9% |
| 2018 |
$0.74 |
$48.82B |
$1.96B |
4% |
| 2019 |
$1.14 |
$47.27B |
$3.06B |
6.5% |
| 2020 |
$1.94 |
$48.19B |
$5.21B |
10.8% |
| 2021 |
$0.00 |
$42.52B |
$9.46M |
0% |
| 2022 |
$0.77 |
$39.13B |
$2.15B |
5.5% |
| 2023 |
$0.92 |
$42.9B |
$2.44B |
5.7% |
| 2024 |
$0.88 |
$40.26B |
$2.35B |
5.8% |
| 2025 |
$0.23 |
$40.4B |
$538M |
1.3% |
